(CNSX:FOX.CN), TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Fox River Resources Corporation (“Fox River” or the “Company”) (CSE: FOX) is excited to announce the successful production of purified phosphoric acid (PPA), a crucial component for the lithium-iron-phosphate (“LFP”) battery supply chain. During this milestone, the Company successfully completed testwork that identified all necessary unit operations […]

(NASDAQ:HYFM), SHOEMAKERSVILLE, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its third quarter ended September 30, 2025. Comparison of Third Quarter vs. Prior Year Period:

TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose Investments”) has updated the investment strategy of the previously named Purpose International Tactical Hedged Equity Fund (TSX: PHW) (the “Fund”). The investment objective of the Fund remains unchanged. In conjunction with the change of investment strategy, the name of the Fund has also been

(NASDAQ:CREX),(NASDAQ:CREXW), LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the fiscal third quarter ended September 30, 2025. Highlights: Third quarter revenue of $10.5 million versus $14.4 million in

(NasdaqGM:CRMD), â€' Q3 2025 Net Revenue of $104.3 million; Pro Forma Net Revenue of $130.8 million â€' â€' Q3 2025 Net Income of $108.6 million; Adjusted EBITDA of $71.9 million â€' â€' FY 2025 Pro Forma Net Revenue Guidance Raised to a Range of $390 to $410 million â€' â€' Conference Call Scheduled for Today

(NasdaqGM:XOMA),(NasdaqGM:XOMAO),(NasdaqGM:XOMAP), Business development: Secures royalty economic interests in two early stage partnered assets through XOMA Royalty's announced expected acquisition of LAVA Therapeutics. Company acquisitions: •Completed XOMA Royalty's acquisitions of Turnstone Biologics and HilleVax; • announced acquisitions of LAVA Therapeutics and Mural Oncology; • acted as structuring agent for XenoTherapeutics' acquisition of ESSA Pharma. Key Pipeline

(NASDAQ:ABEO), – First anticipated ZEVASKYN(R) patient treatment shifted to 4Q 2025 following implementation of optimized release assay – – Strong and growing patient demand and treatment site network, along with broad market access provide foundation for sustainable commercial success – – $207.5M in cash, cash equivalents, restricted cash and short-term investments as of September 30,

(CNSX:TCEC.CN),(OTC US:TCEFF),(Other OTC:TCEFF),(Boerse Frankfurt – Freiverkehr:C9O0), Vancouver B.C., Nov. 12, 2025 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0), is pleased to announce that, further to its press release dated September 24, 2025, the Company has issued a total of 750,000 common shares to the current

(NASDAQ:LTRX), IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its CEO Saleel Awsare will participate in three upcoming investor conferences: 16th Annual Craig-Hallum Alpha Select Conference — Tuesday, Nov. 18, New York City One-on-one meetings

Washington, D.C., Nov. 12, 2025 (GLOBE NEWSWIRE) — Forterra, the company redefining autonomy and mission system interoperability for defense and logistics, today announced it closed a $238 million Series C in equity and debt. The round was led by Moore Strategic Ventures, joined by new investors including Salesforce Ventures, Franklin Templeton, Balyasny Asset Management, 645